Ninth Annual Controversies in Breast Cancer: Adjuvant and Neoadjuvant Therapy
|Event Date/Time: Oct 08, 2010||End Date/Time: Oct 10, 2010|
|Registration Date: Oct 07, 2010|
|Early Registration Date: Aug 30, 2010|
The purpose of this congress is to provide an update on the latest advances in the management of early-stage and locally advanced breast cancer and to address key areas of controversy concerning treatment in those settings.
This educational program is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of breast cancer are also invited to attend.
Topics to be included:
New Breast Cancer Subtypes
Management of DCIS
Hypofractionated radiation therapy
Preoperative therapy decision points
Management of familial breast cancer
Clinical implications of focal HER2 amplification
Chemotherapy in luminal vs. basal breast cancer
Who benefits from angiogenesis inhibitors?
Treating bone micrometastases
Endocrine therapy for life?
Promising novel targeted agents